Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2020 Issue has been successfully launched on 1 November 2020

Abstract

COMPARATIVE STUDIES FOR FILING AND MARKETING AUTHORIZATION OF GENERICS IN EUROPE, UNITED STATES & INDIA

G. Ramakrishna*, M. Bhavya Shalini, Brahmaiah Bonthagarala, M. V. Nagabhushanam and Y. Ratna Sindhu

ABSTRACT

The main aim of the topic to review and compare the generic drug filing process and different aspects of approval between United States Food and Drug Administration (USFDA), European Medical Agency (EMA), and DCGI Drug Controller General Of India approval„s for Marketing Authorization of a drug in US & Europe and India, and their role in improving the standard laid down by them. The goal of the approval process is to provide enough information about the drug which should show safety and efficacy in human beings. ANDA is a regulatory submission for marketing authorization of generic version of drugs in United States. Marketing authorization application (MAA) is the relevant regulatory submission procedure to be followed in the Europe to market a drug. In India Marketing authorization application for generic drugs is the regulatory submission procedure laid down by Drug Controller General of India (DCGI). The Common Technical Document is a common format. A set of specifications for application dossier, for registration of medicines and designed to be used across Europe, United State and India. Quality, Safety and Efficacy information is assembled in a common format through CTD.

Keywords: USFDA, API, DCGI, MAA, EMEA.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More